2025 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those elected will be involved in working on and supporting the BOPA Vision and Strategy, contributing to national objectives and workstreams, advocating for Cancer Pharmacy, supporting our subcommittees and be part of arranging the highly regarded annual conference – plus much more!

The Executive Committee work as a team, supporting each other on behalf of our members and our patients.  The committee has a streamlined format to fit in with busy work schedules for its regular meetings, consisting of a 2-hour tele-conference call once every month, with up to a maximum of two face-to-face meetings during the year.  You will be expected to attend a minimum of 50% of committee meetings every year, and everyone will be expected to lead on a project from our work plan.  It is also an expectation that BOPA related work will take up approximately 1-2 hours/week in addition to the scheduled meetings – it is important that you can commit to this work load.

This is a really exciting opportunity to shape the BOPA Vision and Strategy as well as giving you great experience of working at a national level and building links and relationships with colleagues from across the UK.

This year we are looking for the following positions to fill:

  • Pharmacy Technicians Representative (1 place available)
  • Pharmaceutical Industry Representative (1 place available)

Two standard committee members, Joseph Williams (BOPA Chair) and Anish Tailor (BOPA Treasurer), are also approaching their end of term in office. The Executive Committee have voted to activate Clause 9b of the BOPA constitution and extend their terms by one-year in order to ensure smooth transition of the roles of Executive Officers within the organisation. The election of their standard committee places will therefore be deferred for one-year.

Applicants must be pharmacists or pharmacy technicians in the practice of cancer pharmacy, on the current register of the General Pharmaceutical Council (or registered with an equivalent organisation e.g. overseas), and be current BOPA paid members.

Please note that BOPA cannot offer remuneration to committee members, but travel expenses are reimbursed.

An electronic nomination form is available here. Forms must be submitted by midnight on 8th August 2025. Nominations require the support of two additional BOPA members.

If you wish to find out more about what being a committee member entails, please feel free to contact any of the current members of the committee. They can be contacted through the website (https://www.bopa.org.uk/contact/) or email [email protected]

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article